Search





Search





Markets
/
Stocks
/
cnsp
/

CNS Pharmaceuticals Inc

CNSP

Add to Watchlist

5.760USD

+0.910+18.76%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.64MMarket Cap

LossP/E TTM

CNS Pharmaceuticals Inc

5.760

+0.910+18.76%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CNSP Cash Flow Statement

You can access the annual and quarterly cash flow statements of CNS Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q1

FY2018Q4

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-43.39%-4.65M

44.22%-3.05M

68.03%-2.17M

-223.76%-5.34M

-1.56%-3.24M

-115.70%-5.47M

-101.40%-6.80M

51.50%-1.65M

33.84%-3.19M

-10.02%-2.54M

-86.25%-3.38M

-1.20%-3.40M

-56.79%-4.82M

28.78%-2.31M

9.16%-1.81M

32.72%-3.36M

6.98%-3.08M

-123.73%-3.24M

-56.67%-2.00M

-82.24%-5.00M

-78.32%-3.31M

41.56%-1.45M

---1.27M

---2.74M

-2143.48%-1.86M

-1452.16%-2.48M

67.99%-82.69K

---159.49K

---258.35K

Net income from continuing operations

-14.78%-4.94M

-87.50%-5.96M

42.59%-3.22M

6.16%-2.37M

-21.34%-4.30M

40.91%-3.18M

-23.95%-5.61M

37.07%-2.53M

28.13%-3.54M

2.34%-5.38M

-32.26%-4.52M

-12.77%-4.02M

-77.13%-4.93M

-96.92%-5.50M

10.35%-3.42M

6.50%-3.57M

22.94%-2.78M

6.98%-2.80M

-89.67%-3.81M

-54.16%-3.81M

-83.60%-3.61M

-18.90%-3.00M

---2.01M

---2.47M

-830.55%-1.97M

61.89%-2.53M

31.71%-211.50K

---6.63M

---309.70K

Operating gains losses

69.82%1.87K

3.55%1.02K

-7.19%697.00

46.41%1.10K

34.47%1.10K

3.36%985.00

-16.46%751.00

-25.02%752.00

-36.04%818.00

-59.97%953.00

-67.82%899.00

-68.71%1.00K

-62.10%1.28K

-31.84%2.38K

-17.07%2.79K

-0.12%3.21K

12.58%3.38K

11.10%3.49K

6.51%3.37K

11.77%3.21K

56.39%3.00K

188.44%3.14K

--3.16K

--2.87K

--1.92K

--1.09K

----

Other non-cash items

---4.94M

-593027800.00%-5.93M

-639.74%-3.22M

----

--1.00

--596.30K

----

--334.14K

----

-100.00%0.00

--0.00

-100.00%0.00

-99.29%44.57K

--8.92K

--6.28M

--0.00

Change in working capital

-71.48%284.00K

214.28%2.77M

149.70%1.03M

-563.57%-2.99M

567.84%995.95K

-193.09%-2.43M

-317.13%-2.06M

96.85%645.26K

180.94%149.13K

1.29%2.61M

-27.65%950.06K

472.09%327.79K

70.89%-184.24K

437.54%2.57M

0.33%1.31M

94.68%-88.10K

-393.21%-632.92K

-164.01%-762.05K

254.48%1.31M

-178.59%-1.66M

2.10%-128.33K

746.25%1.19M

--369.22K

---594.81K

-272.75%-131.08K

-1272.86%-184.21K

96.34%75.88K

--15.71K

--38.65K

-Change in receivables

----

--0.00

100.00%0.00

----

--132.65K

--0.00

---132.65K

----

100.00%0.00

----

---6.45K

-Change in prepaid expenses

-147.14%-293.79K

260.87%961.82K

-27.10%401.66K

-1350.83%-1.68M

505.05%623.16K

-174.71%-597.90K

-26.92%550.99K

-188.70%-116.06K

-85.12%102.99K

391.67%800.26K

-13.89%753.94K

322.43%130.85K

117.60%692.22K

-86.62%-274.37K

87.66%875.53K

96.58%-58.83K

360.40%318.12K

-162.54%-147.02K

289.95%466.54K

-230.33%-1.72M

21.75%-122.17K

219.79%235.10K

--119.64K

---519.97K

-1300.95%-156.12K

-494.75%-196.27K

-74.83%13.00K

---33.00K

--51.65K

-Change in payables and accrued expense

54.99%577.79K

199.04%1.81M

125.53%667.20K

-271.73%-1.31M

708.01%372.78K

-238.25%-1.83M

---2.61M

--761.32K

--46.14K

--1.32M

----

--0.00

100.00%0.00

-100.00%0.00

--0.00

---50.00K

624.81%4.17K

4412.97%35.83K

---794.00

--794.00

--0.00

-Change in other current assets

----

--43.70K

---43.70K

----

Cash from non-recurring investing activities

Cash from operating activities

-43.39%-4.65M

44.22%-3.05M

68.03%-2.17M

-223.76%-5.34M

-1.56%-3.24M

-115.70%-5.47M

-101.40%-6.80M

51.50%-1.65M

33.84%-3.19M

-10.02%-2.54M

-86.25%-3.38M

-1.20%-3.40M

-56.79%-4.82M

28.78%-2.31M

9.16%-1.81M

32.72%-3.36M

6.98%-3.08M

-123.73%-3.24M

-56.67%-2.00M

-82.24%-5.00M

-78.32%-3.31M

41.56%-1.45M

---1.27M

---2.74M

-2143.48%-1.86M

-1452.16%-2.48M

67.99%-82.69K

---159.49K

---258.35K

Investing cash flow

Net cash from continuing investing activities

--6.18K

333.98%18.18K

----

94.16%4.19K

----

215800.00%2.16K

15.19%1.74K

----

-100.05%-1.00

--1.51K

--2.91K

-100.00%0.00

--2.08K

--0.00

-100.00%0.00

-42.71%3.67K

-100.00%0.00

--0.00

--11.54K

--6.41K

--11.74K

----

Capital expenditures

--6.18K

333.98%18.18K

----

94.16%4.19K

----

--2.16K

15.19%1.74K

----

--1.51K

--2.91K

-100.00%0.00

--2.08K

--0.00

-100.00%0.00

-42.71%3.67K

-100.00%0.00

--0.00

--11.54K

--6.41K

--11.74K

----

Net cash flow from disposal of fixed assets

--6.18K

333.98%18.18K

----

94.16%4.19K

----

215800.00%2.16K

15.19%1.74K

----

-100.05%-1.00

--1.51K

--2.91K

-100.00%0.00

--2.08K

--0.00

-100.00%0.00

-42.71%3.67K

-100.00%0.00

--0.00

--11.54K

--6.41K

--11.74K

----

Net cash flow from other investing activities

--0.00

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---6.18K

-333.98%-18.18K

----

-94.16%-4.19K

----

-215800.00%-2.16K

-15.19%-1.74K

----

100.05%1.00

---1.51K

---2.91K

100.00%0.00

---2.08K

--0.00

100.00%0.00

42.71%-3.67K

100.00%0.00

--0.00

---11.54K

---6.41K

---11.74K

----

Financing cash flow

Cash flow from continuous financing activities

-95.88%404.66K

-91.80%406.87K

-100.75%-91.62K

90.20%4.43M

184.17%9.83M

127.92%4.96M

146826.13%12.28M

-9.52%2.33M

2975.33%3.46M

-59.17%2.18M

107.14%8.36K

2313.46%2.57M

-101.14%-120.28K

6538.96%5.33M

-103.41%-117.14K

-114.37%-116.17K

2925.97%10.51M

-100.58%-82.83K

7735.92%3.44M

--808.31K

--347.43K

60.60%14.18M

---45.00K

--0.00

100.00%0.00

147051.72%8.83M

-112.30%-48.02K

--6.00K

--390.50K

Net cash flow from debt Issuance/repayment

-10.75%-96.22K

1.27%-30.79K

1.18%-90.97K

1.06%-88.91K

0.93%-86.88K

55.87%-31.19K

26.05%-92.06K

26.76%-89.86K

27.45%-87.70K

10.73%-70.67K

-6.28%-124.49K

-5.60%-122.68K

-4.92%-120.89K

4.42%-79.17K

11.89%-117.14K

11.69%-116.17K

11.48%-115.22K

-92.26%-82.83K

---132.95K

---131.55K

---130.16K

---43.08K

--0.00

100.00%0.00

--0.00

---35.00K

--0.00

Net cash flow from common stock issuance/repurchase

-94.46%500.88K

-89.97%501.75K

-100.00%0.00

86.09%4.51M

155.61%9.03M

39052.63%5.00M

9244.01%12.41M

23.12%2.42M

--3.53M

-99.76%12.78K

--132.85K

--1.97M

-100.00%0.00

--5.41M

-100.00%0.00

7236.07%10.63M

-100.00%0.00

--3.57M

--939.86K

--144.84K

61.84%14.22M

--0.00

----

--8.79M

-100.00%0.00

--0.00

--390.50K

Proceeds from issuance of warrants

----

100.00%0.00

--844.00

-68.80%2.78K

-100.00%0.00

-100.00%-1.00

--0.00

-98.77%8.92K

1936.95%12.40K

1894451.69%2.24M

--0.00

--725.06K

-76.72%609.00

--118.00

--0.00

-99.21%2.62K

--0.00

--332.75K

----

Net cash flow from other financing activities

-100.00%0.00

-540.82%-64.08K

96.28%-1.49K

100.00%0.00

--881.98K

---10.00K

---40.00K

---16.75K

----

--0.00

----

-100.00%0.00

---45.00K

--0.00

100.00%0.00

592.08%41.52K

---13.03K

--6.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-95.88%404.66K

-91.80%406.87K

-100.75%-91.62K

90.20%4.43M

184.17%9.83M

127.92%4.96M

146826.13%12.28M

-9.52%2.33M

2975.33%3.46M

-59.17%2.18M

107.14%8.36K

2313.46%2.57M

-101.14%-120.28K

6538.96%5.33M

-103.41%-117.14K

-114.37%-116.17K

2925.97%10.51M

-100.58%-82.83K

7735.92%3.44M

--808.31K

--347.43K

60.60%14.18M

---45.00K

--0.00

100.00%0.00

147051.72%8.83M

-112.30%-48.02K

--6.00K

--390.50K

Net cash flow

Beginning cash balance

11.45%7.20M

41.46%9.86M

713.23%12.13M

1500.49%13.05M

1077.53%6.46M

666.66%6.97M

-65.14%1.49M

-84.05%815.23K

-94.54%548.72K

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-15.60%7.03M

30.11%8.96M

12.33%12.44M

-64.35%5.00M

537.00%8.33M

162.23%6.89M

105.87%11.08M

93.88%14.04M

45.31%1.31M

--2.63M

--5.38M

1204.42%7.24M

26.94%899.51K

402.19%555.13K

--708.63K

--110.54K

Current period cash flow changes

-164.53%-4.25M

-420.39%-2.66M

-141.33%-2.27M

-235.69%-917.72K

2371.33%6.59M

-41.83%-511.75K

262.67%5.48M

181.36%676.33K

105.39%266.50K

-111.92%-360.83K

-74.47%-3.37M

76.12%-831.28K

-166.50%-4.94M

191.16%3.03M

-234.07%-1.93M

16.90%-3.48M

350.85%7.44M

-126.09%-3.32M

209.25%1.44M

-52.13%-4.19M

-59.24%-2.96M

100.77%12.73M

---1.32M

---2.75M

-1324.11%-1.86M

4231.64%6.34M

-198.92%-130.71K

---153.49K

--132.15K

Ending cash balance

-77.38%2.95M

11.45%7.20M

41.46%9.86M

713.23%12.13M

1500.49%13.05M

1077.53%6.46M

666.66%6.97M

-65.14%1.49M

-84.05%815.23K

-94.54%548.72K

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-15.60%7.03M

30.11%8.96M

12.33%12.44M

-64.35%5.00M

537.00%8.33M

162.23%6.89M

105.87%11.08M

93.88%14.04M

--1.31M

--2.63M

1167.56%5.38M

1204.42%7.24M

74.88%424.42K

--555.13K

--242.69K

Free cash flow

---4.65M

43.93%-3.07M

----

-115.68%-5.48M

----

-10.12%-2.54M

-86.19%-3.38M

----

28.82%-2.31M

9.08%-1.81M

32.66%-3.37M

7.08%-3.08M

-123.87%-3.24M

-56.67%-2.00M

-81.48%-5.00M

-77.91%-3.31M

41.83%-1.45M

---1.27M

---2.75M

---1.86M

---2.49M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did CNS Pharmaceuticals Inc Generate?



CNS Pharmaceuticals Inc generated -13.81M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did CNS Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



CNS Pharmaceuticals Inc's operating cash flow increased by 19.30% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does CNS Pharmaceuticals Inc Spend on Capital Expenditures?



CNS Pharmaceuticals Inc spent 18.18K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has CNS Pharmaceuticals Inc's Financing Cash Flow Changed?



CNS Pharmaceuticals Inc used 14.57M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CNSP?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was CNS Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -13.83M reflecting a 19.21% change from the previous year.